Characterize and assess clinical outcomes of patients receiving tezepelumab after marketing approval in Spain

Trial Identifier: D5180R00038
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: December 2025
Study Completion Date: December 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain, Spain Andalucia, Spain, Spain
Spain, Spain C. Valenciana, Spain, Spain
Spain, Spain C. y Leon, Spain, Spain
Spain, Spain Cantabria, Spain, Spain
Spain, Spain Castilla La Mancha, Spain, Spain
Spain, Spain Cataluna, Spain, Spain
Spain, Spain Extremadura, Spain, Spain
Spain, Spain Galicia, Spain, Spain
Spain, Spain Islas Canarias, Spain, Spain
Spain, Spain Madrid, Spain, Spain
Spain, Spain Navarra, Spain, Spain
Spain, Spain Pais Vasco, Spain, Spain